Monday, 11 August 2025
Doceree, the world's first global network of physician-only platforms for programmatic messaging, announced the integration of its cutting-edge AI-first solution—Spark with Epic, one of the largest electronic health record (EHR) systems in the US. With this expansion, Doceree aims to enhance the capabilities of EHR platforms, providing them with new and wider opportunities to engage health
ArisGlobal, an innovative technology company at the forefront of life sciences and creator of LifeSphere®, announced that another Top 25 global pharmaceutical company has selected LifeSphere NavaX, the next-generation cognitive computing engine, to enhance case processing and pharmacovigilance operations. This milestone marks the sixth major pharmaceutical organization set to implement
Transcripta Bio announced a research collaboration with Microsoft Research to accelerate the discovery of disease-gene associations using advanced artificial intelligence (AI) and large-scale transcriptomic data. This collaboration brings together Transcripta Bio's proprietary Drug-Gene Atlas, which contains over a billion gene responses and full-transcriptome data, and Microsoft Research's mach
AIxMed, an innovator in AI diagnostics for urine cytology and Lumea, a leading provider of primary clinical digital pathology solutions, announced a new partnership. This collaboration will integrate AIxMed's specialized AI technology into Lumea's FDA-cleared digital pathology platform, broadening the advanced diagnostic tools available to the urology market. AIxMed's solution AIxURO is designe
BGM Group Ltd. announced that it has entered into definitive transaction agreements with the existing shareholders of Xingdao Intelligent Cloud Chain (Shenzhen) Co., Ltd. ("Xingdao Intelligent") and YD Network Technology Company Limited ("YD Network"). Under the terms of the agreements, BGM will acquire 100% of the equity interests of both companies at a combined valuation of RMB800 millio
Cathay Innovation has announced the launch of a $1 billion global venture capital fund dedicated entirely to artificial intelligence (AI), marking a pivotal moment in the race to fuel next-generation tech disruptors. This fund, the firm’s largest to date, is backed by industry giants including Sanofi, TotalEnergies, and BNP Paribas Cardif, and is aimed at driving growth in AI-powered start
OMRON Healthcare, a global leader in heart health innovation, announced the launch of its next-generation blood pressure monitors featuring Intellisense™ AFib, the world’s first AI-powered atrial fibrillation (AFib) detection technology integrated directly into a home-use medical device. This revolutionary enhancement allows users to automatically screen for AFib with every sin
Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), announced the launch of its innovative Cloud Lab platform following the successful closure of an oversubscribed $12 million Series A financing round. The new platform allows pharmaceutical companies to develop formulations using Persist AI's state-of-the-art ro
Brainomix, a company pioneering AI-powered imaging solutions in lung fibrosis and stroke, will be presenting new evidence next week at the American Thoracic Society (ATS) Conference in San Francisco validating its Brainomix 360 e-Lung technology to identify progressive pulmonary fibrosis accurately and sensitively. Through a research collaboration with Boehringer Ingelheim, the global leader in
Carnegie Mellon University (CMU), Arm and SoftBank Group Corp. (SBG)announced that Arm and SBG will contribute USD 15.5 million to CMU to support its partnership with Keio University (Keio), a collaboration to accelerate the global advancement of AI. A year ago, the United States and Japan launched a research partnership to accelerate advancements in AI on a global scale. The partnership w
Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform. During the event, Dr. Yue Qian, Executive Director of the AIDD/CADD Platform at Viva Biotech, delivered an in-depth overview of the unique strengths of the AIDD platform, and its three core modules—V-Scepter,
Millennium Dental Technologies, Inc., the leader in laser-assisted regeneration (LAR) technology and innovative procedures, announced at the annual California Dental Association (CDA) convention in Anaheim the launch of the LANAP® AI Workflow in collaboration with Zyris, Inc., a leading manufacturer of dental isolation systems. The new workflow integrates the company's PerioLase MVP-7 laser
Clarivate Plc , a leading global provider of transformative intelligence, announced the incorporation of Pathway Maps in OFF-X, a cutting-edge translational safety intelligence solution. With over 30% of drug development failures attributed to safety issues1, preclinical and translational research teams face increasing pressure to identify potential liabilities earlier in the target selection pr
VUNO, a leading South Korean medical AI company, announced today that its flagship AI-powered cardiac arrest risk management system VUNO Med®-DeepCARS®(DeepCARS) has received CE MDR (Medical Device Regulation) certification in the European Union, as well as the UKCA (UK Conformity Assessed) mark in the United Kingdom. Achieving these regulatory milestones more than a year ahead of schedu
- Clarium, the company powering the world's first and market-leading AI-powered healthcare supply chain resiliency platform, announced a $27 million Series A funding round from Northzone, with participation from existing investors including General Catalyst, AlleyCorp, Kaiser Permanente Ventures, Texas Medical Center Ventures, and 1984 Ventures. This round brings Clarium's total funding to $43 m
European College of Sport and Exercise Physicians (ECOSEP) and Tata Elxsi have announced a strategic partnership that aims to revolutionise the field of sports and exercise medicine through combining the research excellence and clinical expertise of ECOSEP with Tata Elxsi's AI- and machine learning–driven healthcare solutions and technology capabilities. The partnership will focus on appl
Dawn Health and Merck have launched the next-generation digital ecosystem for growth disorders, designed to support patients with Growth Hormone Deficiency (GHD), their caregivers, and healthcare professionals (HCPs). This marks a step forward in digital solutions for GHD, enhancing accessibility, usability, and clinical support. Over the past year, Dawn Health and Merck have worked closely to ev
HistoIndex, known for its groundbreaking biophotonic Second Harmonic Generation (SHG) technology and a pioneering leader in Artificial Intelligence (AI) digital pathology for the management of fibrotic diseases, has announced the close of a S$9 million investment round to support its next phase of expansion. OCBC, the longest established bank in Singapore and the second largest financial service
Andor Health, the AI company reimagining virtual care with the #1 AI software infrastructure for healthcare, expands AI-first ThinkAndor® capabilities at Sentara Health. Sentara is among the top 20 largest not-for-profit integrated health systems in the country, with 34,000 employees, 12 hospitals in Virginia and Northeastern North Carolina, and the Sentara Health Plans division which serves
Andor Health, the AI company reimagining virtual care with the #1 AI software infrastructure for healthcare, expands AI-first ThinkAndor® capabilities at Sentara Health. Sentara is among the top 20 largest not-for-profit integrated health systems in the country, with 34,000 employees, 12 hospitals in Virginia and Northeastern North Carolina, and the Sentara Health Plans division which serves
As artificial intelligence rapidly transforms global industries, India’s KnowDis AI is charting a distinct path by fusing foundational research with real-world applications tailored to the country's needs. In this exclusive interview with AI Reporter Asia (AI Reporter America), Neeta Singal, Partner and Co-Founder of KnowDis AI, outlines the company’s ambitious 2025 inn
Blooming Health, a social care technology platform, announced it has raised $26 million in a Series A funding round led by global software investor Insight Partners, with participation from existing investors Afore Capital, Crossbeam Venture Partners, and Metrodora Ventures. This investment brings Blooming Health's total funding to $32.5 million. The round comes as Blooming Health accelera
By subscribing, you agree to receive email related to content and products. You unsubscribe at any time.
Copyright 2025, AI Reporter America All rights reserved.
